Visual and Auditory Electromyography Biofeedback Among Stroke Patients (NCT07710937) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Visual and Auditory Electromyography Biofeedback Among Stroke Patients
Pakistan84 participantsStarted 2026-04-09
Plain-language summary
Stroke commonly results in impairments of balance, mobility, and lower extremity motor function that limit independence in daily activities. Electromyography (EMG) biofeedback enhances motor relearning by providing real-time feedback regarding muscle activation. Although both visual and auditory EMG biofeedback have demonstrated benefits in stroke rehabilitation, evidence directly comparing these feedback modalities remains limited. This randomized controlled trial aims to compare the effects of visual and auditory EMG biofeedback, each combined with conventional physiotherapy, on balance, functional mobility, motor function, and functional independence in individuals with stroke.
Who can participate
Age range
40 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 20 and 30 years
* Male or female participants
* Clinically diagnosed hemiplegic stroke.
* Medically stable and able to participate in rehabilitation.
* No visual impairment that would interfere with visual biofeedback.
* No hearing impairment that would interfere with auditory biofeedback.
* No sensory aphasia affecting the ability to understand study instructions.
Exclusion Criteria:
* Traumatic injury or lesion affecting the lower extremities
* Lower-limb amputation
* Severe systemic disease that could interfere with participation
* Peripheral vascular disease affecting the lower extremities
* Fixed ankle contracture
* Motion sickness or intolerance to rehabilitation technology
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Balance (Berg Balance Scale)
Timeframe: Baseline and Week 3 (Post-intervention)
2
Functional mobility (Timed Up and Go Test)
Timeframe: Baseline and Week 3 (Post-intervention)
3
Motor function (Fugl-Meyer Assessment-Lower Extremity)
Timeframe: Baseline and Week 3 (Post-intervention)